OpenBilldrug price receipt

NADAC week of 2026-10-14

DRIZALMA SPRINKLE DR 40 MG CAP

FDA nonproprietary name: duloxetine

For 30 capsules

Pharmacies pay

$215.10 filed

30 × $7.16995 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$252.37 estimated

$215.10 + $32.27 (15%) + $5.00 fee per fill = $252.37

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

DRIZALMA SPRINKLE DR 40 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as duloxetine, under the trade name “DRIZALMA SPRINKLE”.

FDA gives its dosage form as capsule, delayed release and its route as oral.

The labeler, the company named on the label, is SUN PHARMACEUTICAL INDUSTRIES, INC.

FDA’s Established Pharmacologic Class for it is Serotonin and Norepinephrine Reuptake Inhibitor.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 47335-0618-30.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $215.10 for 30 capsules (30 × $7.16995 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

7 other products in the NADAC file share the FDA nonproprietary name duloxetine with DRIZALMA SPRINKLE DR 40 MG CAP.

ProductPharmacies pay per unitMedicare per unit
DRIZALMA SPRINKLE DR 20 MG CAP
brand · capsule, delayed release
$7.04433 per EA filed
eff. 2026-09-23
We don’t know yet
DRIZALMA SPRINKLE DR 30 MG CAP
brand · capsule, delayed release
$7.23088 per EA filed
eff. 2026-09-23
We don’t know yet
DRIZALMA SPRINKLE DR 40 MG CAP this page
brand · capsule, delayed release
$7.16995 per EA filed
eff. 2026-09-23
We don’t know yet
DRIZALMA SPRINKLE DR 60 MG CAP
brand · capsule, delayed release
$7.15216 per EA filed
eff. 2026-09-23
We don’t know yet
DULOXETINE HCL DR 20 MG CAP
generic · capsule, delayed release pellets / capsule, delayed release
$0.11867 per EA filed
eff. 2026-09-23
$0.35062 per EA filed
Part D 2024 average
DULOXETINE HCL DR 30 MG CAP
generic · capsule, delayed release pellets / capsule, delayed release
$0.10243 per EA filed
eff. 2026-09-23
$0.35062 per EA filed
Part D 2024 average
DULOXETINE HCL DR 40 MG CAP
generic · capsule, delayed release / capsule, delayed release pellets
$1.24391 per EA filed
eff. 2026-09-23
$0.35062 per EA filed
Part D 2024 average
DULOXETINE HCL DR 60 MG CAP
generic · capsule, delayed release pellets / capsule, delayed release
$0.13493 per EA filed
eff. 2026-09-23
$0.35062 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $7.16995 per EA filed.

Of the 43 other products in FDA’s Serotonin and Norepinephrine Reuptake Inhibitor class priced per EA, 15 have a higher middle NADAC price and 28 a lower one. The one in the middle is MILNACIPRAN HCL 50 MG TABLET, at $2.80179 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.